Enterprise Value
127.6M
Cash
11.73M
Avg Qtr Burn
N/A
Short % of Float
0.18%
Insider Ownership
16.60%
Institutional Own.
7.38%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
EVX-01 + pembrolizumab Details Solid tumor/s, Cancer, Melanoma | Phase 2 Data readout | |
EVX-02 Details Melanoma | Phase 1/2 Update |